BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22573589)

  • 1. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
    Pelaez T; Gijón P; Bunsow E; Bouza E; Sánchez-Yebra W; Valerio M; Gama B; Cuenca-Estrella M; Mellado E
    J Clin Microbiol; 2012 Jul; 50(7):2531-4. PubMed ID: 22573589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
    Bellete B; Raberin H; Morel J; Flori P; Hafid J; Manhsung RT
    Med Mycol; 2010 Feb; 48(1):197-200. PubMed ID: 20055745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
    Krishnan Natesan S; Wu W; Cutright JL; Chandrasekar PH
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):272-7. PubMed ID: 22897872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
    Gregson L; Goodwin J; Johnson A; McEntee L; Moore CB; Richardson M; Hope WW; Howard SJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5778-80. PubMed ID: 24041890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole preexposure affects the Aspergillus fumigatus population in patients.
    Alanio A; Cabaret O; Sitterlé E; Costa JM; Brisse S; Cordonnier C; Bretagne S
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4948-50. PubMed ID: 22710122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
    Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
    Escribano P; Recio S; Peláez T; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2011 May; 55(5):2460-2. PubMed ID: 21321141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
    Atamna A; Yeshurun M; Shargian L; Raanani P; Kramer M; Ben Zvi H; Ben Ami R; Marr KA; Bishara J
    J Antimicrob Chemother; 2024 May; 79(5):1191-1192. PubMed ID: 38334380
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.
    Nawrot U; Kurzyk E; Arendrup MC; Mroczynska M; Wlodarczyk K; Sulik-Tyszka B; Wróblewska M; Ussowicz M; Zdziarski P; Niewinska K; Brillowska-Dabrowska A
    Med Mycol; 2018 Jan; 56(1):121-124. PubMed ID: 28340159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Vazquez JA; Manavathu EK
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1129-33. PubMed ID: 26574014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Krishnan-Natesan S; Wu W; Chandrasekar PH
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
    J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
    Seyedmousavi S; Meletiadis J; Melchers WJ; Rijs AJ; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):796-803. PubMed ID: 23183435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Xu J; Sharma C; Sundar G; Singh PK; Gaur SN; Hagen F; Klaassen CH; Meis JF
    PLoS One; 2012; 7(12):e52871. PubMed ID: 23285210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
    Howard SJ; Cerar D; Anderson MJ; Albarrag A; Fisher MC; Pasqualotto AC; Laverdiere M; Arendrup MC; Perlin DS; Denning DW
    Emerg Infect Dis; 2009 Jul; 15(7):1068-76. PubMed ID: 19624922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
    J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.